Overexpression of vasopressin in the rat transgenic for the metallothionein-vasopressin fusion gene

in Journal of Endocrinology
Authors:
H Nagasaki
Search for other papers by H Nagasaki in
Current site
Google Scholar
PubMed Close
,
H Yokoi
Search for other papers by H Yokoi in
Current site
Google Scholar
PubMed Close
,
H Arima
Search for other papers by H Arima in
Current site
Google Scholar
PubMed Close
,
M Hirabayashi
Search for other papers by M Hirabayashi in
Current site
Google Scholar
PubMed Close
,
S Ishizaki
Search for other papers by S Ishizaki in
Current site
Google Scholar
PubMed Close
,
K Tachikawa
Search for other papers by K Tachikawa in
Current site
Google Scholar
PubMed Close
,
T Murase
Search for other papers by T Murase in
Current site
Google Scholar
PubMed Close
,
Y Miura
Search for other papers by Y Miura in
Current site
Google Scholar
PubMed Close
, and
Y Oiso
Search for other papers by Y Oiso in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.1677/joe.0.1730035
Volume/Issue:
Volume 173: Issue 1
Article Type:
Other
Page Range:
35–44
Online Publication Date:
01 Apr 2002
Free access

Sign up for journal news

Arginine vasopressin (AVP) is a major antidiuretic hormone, the overproduction of which causes diluting hyponatremia in humans and is called the syndrome of inappropriate antidiuresis (SIAD). To study physiological changes resulting from AVP overproduction and to develop an animal model of hyponatremia, the human AVP gene was expressed under the control of the metallothionein promoter in transgenic (Tg) rats. Analyses of AVP immunoreactivity (irAVP) in the tissues revealed that the transgene is expressed mainly in the central nervous system. Gel filtration showed that irAVP in the brain and plasma was properly processed AVP. AVP purified from the brains of both Tg and control rats also exerted equal bioactivity to generate cAMP in LLC-PK1 cells. The founder rats did not show any physical or anatomical abnormalities. Under basal conditions, Tg rats had high plasma AVP levels (Tg 13.8 +/- 2.5 pg/ml; control 2.7 +/- 1.2 pg/ml; n=6 in both groups; means +/- S.E.M.), decreased urine volume, and normal plasma [Na(+)]. Hypertonic saline injected i.p. did not affect AVP secretion in Tg rats. In response to a zinc-supplemented liquid diet, plasma AVP decreased in control rats, but increased in Tg rats (Tg 32.7 +/- 2.7 pg/ml; control 1.0+/-0.1 pg/ml; n=6), resulting in hyponatremia (Tg 135.2 +/- 2.5 mEq/l; control 140.8 +/- 0.4 mEq/l; n=6). To our knowledge, this is the first transgenic animal to show diluting hyponatremia. This transgenic rat may therefore provide a useful model in which to investigate various physiological alterations resulting from the oversecretion of AVP which involve SIAD, stress response, behavior, and blood pressure.

Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 206 88 16
PDF Downloads 166 55 5

 

  • Collapse
  • Expand
Print ISSN:
0022-0795
Online ISSN:
1479-6805
Page(s):
10
Article Type:
Other
Print Publication Date:
01 Apr 2002
Online Publication Date:
01 Apr 2002